TORC Insider Trading Activity and SEC Form 4 Filings
TORC insider trading summary
No open-market insider purchases or sales of resTORbio, Inc. (TORC) have been reported on SEC Form 4 in the past 12 months.
Latest TORC insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 18, 2019 | PureTech Health LLC | 10% Owner | Sell | $7.4M (6,161,531 @ $1.20) |
| Dec 13, 2019 | PureTech Health LLC | 10% Owner | Sell | $256K (205,763 @ $1.24) |
| Dec 12, 2019 | PureTech Health LLC | 10% Owner | Sell | $482K (385,884 @ $1.25) |
| Dec 11, 2019 | PureTech Health LLC | 10% Owner | Sell | $75K (59,921 @ $1.25) |
| Dec 10, 2019 | PureTech Health LLC | 10% Owner | Sell | $424K (336,561 @ $1.26) |
| Nov 15, 2019 | PureTech Health LLC | 10% Owner | Sell | $662K (531,040 @ $1.25) |
| Apr 16, 2018 | Chen Schor | President and CEO | Buy | $18K (2,000 @ $8.95) |
| Apr 11, 2018 | Chen Schor | President and CEO | Buy | $19K (2,000 @ $9.36) |
| Apr 10, 2018 | Chen Schor | President and CEO | Buy | $17K (2,000 @ $8.46) |
| Jan 30, 2018 | Orbimed Advisors LLC | Director | Buy | $8.0M (533,333 @ $15.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.